Healthcare plans

The DOL upended the traditional dynamic of company-sponsored benefits and threw a lifeline to millions of small companies and their HR teams.

Attempting to circumvent the costly specialty drug chain, brokers are encouraging clients to shop for FDA-approved drugs outside the U.S.

The health venture established will take aim at intermediaries in the healthcare system as a part of a broad effort to reduce wasteful spending

The Cognoa solution advises parents of a possible developmental delays during a child's early years, recommend therapies.

The world’s biggest pharmaceutical companies, looking to sell a new type of cancer drug that could transform treatment, are grappling with an unusual challenge: finding patients.

The CEO of the Amazon-JPMC-Berkshire Hathaway aims to address the “tapeworm” eating the U.S. economy.

Atul Gawande receives high praise from industry professionals; however determining who will support his plans remains a mystery.

By passing this popular bipartisan legislation now, Congress can help make coverage and care more affordable for everyone.

Atul Gawande, the surgeon and journalist who has written extensively about America’s failure to grapple with an inefficient healthcare system, has been named to head a new venture for Amazon, Berkshire Hathaway and JPMorgan Chase.

Smaller insurers are often hesitant at first. But encouraged by benefit brokerages like Lockton Companies, they are increasingly embracing this cost saving paradigm.